ISIN | LU1038902505 |
---|---|
Valor Number | 23755279 |
Bloomberg Global ID | UEGIPUD LX |
Fund Name | UBS (Lux) Key Selection SICAV - European Growth and Income (EUR) (USD hedged) P-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Asset Allocation |
EFC Category | Multi-Asset Advanced Europe Defensive USD |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The actively managed sub-fund uses a composite benchmark (see below) as reference for portfolio construction, performance evaluation and risk management purposes. For share classes with “hedged” in their name, currency-hedged versions of the relevant benchmark (if available) are used. Although part of the relevant portfolio may be invested in the same instruments and applying the same weightings as the relevant benchmark, the Portfolio Manager is not constrained by the relevant benchmark in terms of choice of instruments. The Portfolio Manager may use other instruments in pursuit of the investment strategy. The performance of the sub-funds may therefore differ considerably from the relevant benchmark in periods of high market volatility. |
Peculiarities |
Current Price * | 175.50 USD | 02.04.2025 |
---|---|---|
Previous Price * | 175.71 USD | 01.04.2025 |
52 Week High * | 178.23 USD | 03.03.2025 |
52 Week Low * | 159.79 USD | 16.04.2024 |
NAV * | 175.50 USD | 02.04.2025 |
Issue Price * | 175.50 USD | 02.04.2025 |
Redemption Price * | 175.50 USD | 02.04.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 414,979,167 | |
Unit/Share Assets *** | 15,397,144 | |
Trading Information SIX |
YTD Performance | +3.61% |
31.12.2024 - 02.04.2025
31.12.2024 02.04.2025 |
---|---|---|
YTD Performance (in CHF) | +0.65% |
31.12.2024 - 02.04.2025
31.12.2024 02.04.2025 |
1 month | -1.53% |
03.03.2025 - 02.04.2025
03.03.2025 02.04.2025 |
3 months | +3.38% |
02.01.2025 - 02.04.2025
02.01.2025 02.04.2025 |
6 months | +3.52% |
02.10.2024 - 02.04.2025
02.10.2024 02.04.2025 |
1 year | +8.72% |
02.04.2024 - 02.04.2025
02.04.2024 02.04.2025 |
2 years | +20.21% |
03.04.2023 - 02.04.2025
03.04.2023 02.04.2025 |
3 years | +17.86% |
04.04.2022 - 02.04.2025
04.04.2022 02.04.2025 |
5 years | +52.38% |
02.04.2020 - 02.04.2025
02.04.2020 02.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 1.70 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 02.04.2025 |
UBS (Lux) BFConvert Eurp EUR U-X EUR Inc | 19.01% | |
---|---|---|
UBS (Lux) ES Eurp Opp Uncons € U-X | 18.47% | |
UBS(LUX) ES Eurp Hi DivSsEUR U-X-acc | 14.49% | |
UBS (Lux) BS Convt Glbl € I-X-dist | 14.17% | |
Teva Pharmaceutical Finance Netherlands II B.V 7.375% | 0.65% | |
Nidda Healthcare Holding GmbH 7.5% | 0.38% | |
CPI Property Group S.A. 4.875% | 0.38% | |
Golden Goose SpA 7.898% | 0.32% | |
Virgin Media Vendor Financing Notes III Designated Activity Company 4.875% | 0.31% | |
TVL Finance PLC 10.25% | 0.30% | |
Last data update | 31.01.2025 |
TER | 1.81% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 1.40% |
Ongoing Charges *** | 1.82% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |